Clinical Trial Update: Berotralstat Treatment in Children With Hereditary Angioedema [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting results for berotralstat in pediatric hereditary angioedema; the study is active but not recruiting, with results posted on 2026-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• Berotralstat (berotralstat)

Snippet

Sponsor: BioCryst Pharmaceuticals | Conditions: Hereditary Angioedema, Pediatric | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-02-25